Spelling suggestions: "subject:"huntington's chorea"" "subject:"huntingtons's chorea""
11 |
NEUROTRANSMITTER AND RECEPTOR ALTERATIONS IN NEUROPSYCHIATRIC DISEASESWastek, Gregory John, 1947- January 1978 (has links)
No description available.
|
12 |
Gamma-aminobutyric acid and glutamic acid in Huntington's Disease: investigation of neurotransmitter receptors using radiolabeled agonistsBeaumont, Kevin January 1979 (has links)
No description available.
|
13 |
Study of Huntington's disease in Drosophila melanogaster : screening for polyQ modifiers and studying the effects of vesicle trafficking and autophagy inhibitionChen, Chien-Wen January 2011 (has links)
No description available.
|
14 |
Degradation of the Huntington polyglutamine domain by the proteasome implication to Huntington's disease /Blaize, Marie Antoinette. January 2008 (has links) (PDF)
Thesis (M.S.)--University of Alabama at Birmingham, 2008. / Description based on contents viewed Oct. 14, 2008; title from PDF t.p. Includes bibliographical references (p. 53-59).
|
15 |
"I have the gene, but I don't have Huntington disease" : negotiating genetic risk /Etchegary, Holly, January 2005 (has links)
Thesis (Ph.D.)--Memorial University of Newfoundland, 2005. / Bibliography: leaves 370-404.
|
16 |
Investigating the role of Huntingtin in development and disease using the zebrafish model organism.Lumsden, Amanda Louise January 2007 (has links)
Huntington’s disease (HD) is a dominantly inherited neurodegenerative disorder of typically mid-life onset, for which there is currently no cure. HD is one of nine neurological disorders caused by the expansion of a CAG trinucleotide repeat that encodes an extended polyglutamine tract within the respective disease proteins (which, in the case of HD, is Huntingtin). Curiously, despite these proteins having mostly widespread patterns of expression in the brain, a specific subset of neurons is preferentially affected in each disease, whilst other neurons also expressing the mutant protein are relatively unaffected. Furthermore, although the expression patterns of these disease proteins often overlap in distribution within the brain, the population of neurons that is most vulnerable differs from one disease to the next. Knowledge of what determines the specificity of neuronal vulnerability is likely to provide insight into the molecular mechanism(s) underlying the pathology in these diseases. The aim of this work was to use the zebrafish model organism to investigate two factors hypothesised to contribute to the specificity of neuronal vulnerability in HD: 1) region-specific somatic expansion of the disease allele, and 2) disruption of normal Huntingtin (Htt) protein function. The most significant findings of this study resulted from the investigation into the normal function of Htt. Antisense morpholino oligonucleotides were used to specifically knock down Htt expression in early zebrafish development, resulting in a wide variety of developmental defects. Most notably, Htt-deficient zebrafish had pale blood due to a decrease in haemoglobin production, despite the presence of (apparently unavailable) iron within these cells. Provision of additional iron in a bio-available form to the cytoplasm restored haemoglobin production in Htt-deficient embryos. Since blood cells acquire iron via receptor-mediated endocytosis of transferrin, these results suggest a role for Htt in the release of iron from endocytic compartments into the cytosol. Iron is required for the function of many cellular proteins and enzymes that play key roles in oxidative energy production. Disrupted iron homeostasis and decreased energy metabolism are features of HD pathogenesis that correlate to the major sites of degeneration in the HD brain. The findings of this study raise the possibility that perturbation of normal Htt function (by polyglutamine expansion) may contribute to these defects, thereby providing a novel link between Htt function and specificity of neuronal vulnerability in HD. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1274748 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2007
|
17 |
Olfactory psychophysics and electrophysiology in Huntington's Disease /Wetter, Spencer Ryan. January 2003 (has links)
Thesis (Ph. D.)--University of California, San Diego and San Diego State University, 2003. / Vita. Includes bibliographical references.
|
18 |
The development and optimization of biomarkers for Huntington's and Parkinson's disordersAntoniades, Chrystalina Andrea January 2010 (has links)
No description available.
|
19 |
Semantic memory for olfaction and vision in patients with Alzheimers's disease, Huntington's disease, and normal individuals /Razani, Laleh Jill, January 1998 (has links)
Thesis (Ph. D.)--University of California, San Diego, 1998. / Vita. Includes bibliographical references (leaves 165-174).
|
20 |
Distingushing Huntington's dementia from Alzheimer's dementia in clinical trial batteries.Walker, Denise (Denise Lynn), Carleton University. Dissertation. Psychology. January 1992 (has links)
Thesis (M.A.)--Carleton University, 1993. / Also available in electronic format on the Internet.
|
Page generated in 0.084 seconds